• About
  • Services
  • Clients
  • Client News
  • PCG Research
  • PCG Digital
  • Contact
  • follow:

  • 2 Mar

    Lexaria’s DehydraTECH-CBD Diabetes Study Demonstrates Weight Loss, Improved Triglyceride and Cholesterol Levels

    KELOWNA, BC / ACCESSWIRE / March 2, 2023 / Lexaria Bioscience Corp. (Nasdaq:LEXX) (Nasdaq:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces that its diabetes animal model study DIAB-A22-1 has completed and produced at least three positive outcomes including weight loss in obese diabetic-conditioned animals, together… Read More..

    Share this:
  • 1 Mar

    SuperCom Launches $3.6 Million National Electronic Monitoring Project in Finland

    Project Deployment and Recurring Revenue Generation Expected to Start in the Near Future TEL AVIV, Israel, March 1, 2023 /PRNewswire/ -- SuperCom (NASDAQ: SPCB), a global provider of secure solutions for the e-Government, IoT, and Cybersecurity sectors, announced it has launched a $3.6 million project with the national government of Finland… Read More..

    Share this:
  • 1 Mar

    Blackboxstocks Retires 687,761 Common Shares Held in Treasury

    DALLAS, March 01, 2023--(BUSINESS WIRE)--Blackboxstocks Inc. (NASDAQ: BLBX), ("Blackbox" or the "Company"), a financial technology and social media hybrid platform offering real-time proprietary analytics for stock and options traders of all levels, announced today that it has retired 687,761 common shares the Company repurchased and held in Treasury. The shares… Read More..

    Share this:
« Previous 1 … 191 192 193 194 195 … 263 Next »
  • Twitter feed is not available at the moment.
  • QUICK LINKS

    • About
    • Services
    • Clients
    • Client Media
    • PCG Media
    • PCG Research
    • Contact
    • Privacy Policy
    • Disclosures

    FOLLOW US

    Copyright © 2022 PCG Advisory.

    MENU logo
    • About
    • Services
    • Clients
    • Client News
    • PCG Research
    • PCG Digital
    • Contact